Wednesday, December 4, 2024
Home > Trials (Page 2)

HSBC, Standard Chartered Set to Run Tokenization Trials for Singapore’s MAS

The initiative, Project Guardian, has enlisted 11 institutions to test asset tokenization across financial asset classes. Pilot studies across wealth management, fixed income and foreign exchange will be carried out by banking giants such as HSBC, Standard Chartered, DBS and Citi, according to the announcement. Source

Read More

Blockchain Anti-Counterfeiting Trials ‘Promising,’ Europe’s EUIPO Says

EUIPO has finalized a proof of concept "having engaged in real-life operational tests with four brands, two logistics operators and a customs authority,” following a months-long trial, which showed “promising results,” the agency said of an initiative now known as European Logistics Services Authentication (ELSA), based on a separate project

Read More

SBF upset by criminal trial’s late evidence while FTX seeks sale of AI stock

Former FTX CEO Sam Bankman-Fried claims prosecutors have missed discovery deadlines for key pieces of evidence required in the defense of a raft of fraud charges.On June 5, Bankman-Fried’s lawyers told United States District Judge Lewis A. Kaplan in a letter that the government had not turned over all of

Read More

Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface

Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in-human” trials for its surgically implanted brain device. Congratulations Neuralink team! https://t.co/AWZGf33UDr— Elon Musk (@elonmusk) May 26, 2023 It’s unclear at this time what kind of trials the

Read More

Elon Musk’s Neurotech Company Neuralink Seeks Partner to Begin Human Trials Phase

Neuralink is looking for a partner to conduct human trials for brain implants and has approached a leading neurological treatment centre. Elon Musk‘s brain implant company Neuralink is reportedly searching for a human trials partner and is in talks with several medical centers. Among these is the Arizona-based neurological disease treatment and

Read More

Singapore’s MAS says no urgent case for retail CBDC, but launches 4 fast trials of it

The Monetary Authority of Singapore (MAS) has wrapped up the first stage of its Project Orchid examination of a retail central bank digital currency (CBDC). According to the white paper released on Oct. 31, there is no “urgent case” for a retail CBDC in Singapore, but the study envisioned the infrastructure required

Read More